CN1375320A - Chinese medicine for treating hyperosteogeny and its prepn. - Google Patents
Chinese medicine for treating hyperosteogeny and its prepn. Download PDFInfo
- Publication number
- CN1375320A CN1375320A CN 02109377 CN02109377A CN1375320A CN 1375320 A CN1375320 A CN 1375320A CN 02109377 CN02109377 CN 02109377 CN 02109377 A CN02109377 A CN 02109377A CN 1375320 A CN1375320 A CN 1375320A
- Authority
- CN
- China
- Prior art keywords
- drying
- hours
- time
- mixing
- caulis spatholobi
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
This invention relates to a medicine for treating hyperosteogeny which comprises Semen, drynaria rhizome, pyrole notundifolia, Cistanche salsa and reticulate millettia etc. and its preparation method thereof. The preparation method incldues grinding 7% of Caulis Spatholobiinto fine powder, decocting the rest of Caulis Spatholobiinto and above said other medicines with water by twice (the first time foe 3 hours and the second time for 2 hours), filtering, mixing the two filtrations, concentrating into thick paste, adding said fine powder, mixing, drying, disintegrating, adding some additional material and uniformly mixing, granulating and drying to make tablets which has the functions of supplementing kidney, promoting blood circulation and relieving pain and is used for treating hypertrophic spondilitis, cervical spondylosis and proliferative arthritis.
Description
Technical field: the present invention relates to a kind of Chinese medicine and processing technology for the treatment of hyperosteogeny.
Background technology: hyperosteogeny phenomenon is in various degree arranged more than 70% among the present crowd more than 45 years old, and the medicine of existing treatment hyperosteogeny only has analgesic effect, does not have therapeutical effect, thereby medication effect is relatively poor.
Summary of the invention: the purpose of this invention is to provide a kind of Chinese medicine for the treatment of hyperosteogeny, make by weight percentage by following raw materials according,
Semen Raphani 7.8-9.9 Rhizoma Drynariae 13-15 Herba Pyrolae 13-15
Herba Cistanches 13-15 Caulis Spatholobi 13-15
Radix Rehmanniae Preparata 20-22 Herba Epimedii 13-15
Its processing technology is: with above seven flavor medicine, get 7% Caulis Spatholobi and be ground into fine powder, Six-elements such as residue Caulis Spatholobi and all the other Radix Rehmanniae Preparata decoct with water secondary, 3 hours for the first time, 2 hours for the second time, filter, merging filtrate is condensed into thick paste, adds above-mentioned powder, mix, drying is pulverized, add right amount of auxiliary materials, mixing is granulated, drying, compacting are in flakes.
Tool the kidney invigorating of the present invention, the effect of invigorating blood circulation, softening bony spur, anti-inflammatory analgetic are used for hypertrophic spondylitis, cervical spondylosis, calcanean spur, proliferative arthritis, Kaschin-Beck disease.Bony spur, one week of cervical spondylosis are can cure in 3-4 week.
Scientific formulation of the present invention, rigorous, unique, Radix Rehmanniae Preparata, Herba Pyrolae, Rhizoma Drynariae, Herba Cistanches, Herba Epimedii are all with the effect of the strong muscle of essence and blood, the kidney invigorating of nourishing the liver and kidney.Promoting blood circulation and stopping pain dredge the meridian passage, mass dissipating and swelling eliminating, expelling wind and removing dampness are helped with Caulis Spatholobi, Semen Raphani relaxing muscles and tendons to promote blood circulation, the therapeutic method to keep the adverse QI flowing downwards of enriching blood, sector-style gas, sharp joint again.To low card as wind, wet, low etc. and have very high curative effect.Evident in efficacy to arthrosiss such as cervical spondylosis, lumbar spondylosis, hyperosteogeny, scapulohumeral periarthritis, rheumatism and rheumatoid, arthritis and soft tissue injury, strain.Catch homologous tonifying liver, kidney, gas, the blood now discussed of blood simultaneously, the mechanism of expelling wind and removing dampness, reducing swelling and alleviating pain is put forth effort on and is effected a permanent cure, and actively takes stopgap measures, treating both the principal and secondary aspects of a disease.
According to incompletely statistics, about 45%, particularly the relatively poor regional sickness rate of the north and water quality is higher at the crowd's sickness rate more than 35 years old the age.Clinically show by the observation of curative effect result to 280 routine patients: total effective rate is 88.2%; What significant curative effect was arranged is 65.8%.Therefore comprehensive above-mentionedly can be used for treating hypertrophic spondylitis, cervical spondylosis, calcanean spur, proliferative arthritis, Kaschin-Beck disease.Clinical observation has no side effect.
The specific embodiment:
Embodiment: a kind of Chinese medicine for the treatment of hyperosteogeny, make unit by following raw materials according: gram;
Semen Raphani 86 Rhizoma Drynariae 136 Herba Pyrolaes 136
Herba Cistanches 136 Caulis Spatholobis 136
Radix Rehmanniae Preparata 204 Herba Epimedii 136
Its processing technology is: with above seven flavor medicine, the Caulis Spatholobi of getting 68 grams is ground into fine powder, and Six-elements such as residue Caulis Spatholobi and all the other Radix Rehmanniae Preparata decoct with water secondary, 3 hours for the first time, 2 hours for the second time, filter, merging filtrate is condensed into thick paste, adds above-mentioned powder, mix, drying is pulverized, add right amount of auxiliary materials, mixing is granulated, drying, compacting are in flakes.Above-mentioned raw materials can be made into 1000.
Instructions of taking: oral, one time 4,2 times on the one.
Claims (1)
1, a kind of Chinese medicine for the treatment of hyperosteogeny is characterized in that it is made by weight percentage by following raw materials according,
Semen Raphani 7.8-9.9 Rhizoma Drynariae 13-15 Herba Pyrolae 13-15
Herba Cistanches 13-15 Caulis Spatholobi 13-15
Radix Rehmanniae Preparata 20-22 Herba Epimedii 13-15
Its processing technology is: with above seven flavor medicine, get 7% Caulis Spatholobi and be ground into fine powder, Six-elements such as residue Caulis Spatholobi and all the other Radix Rehmanniae Preparata decoct with water secondary, 3 hours for the first time, 2 hours for the second time, filter, merging filtrate is condensed into thick paste, adds above-mentioned powder, mix, drying is pulverized, add right amount of auxiliary materials, mixing is granulated, drying, compacting are in flakes.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 02109377 CN1375320A (en) | 2002-04-01 | 2002-04-01 | Chinese medicine for treating hyperosteogeny and its prepn. |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 02109377 CN1375320A (en) | 2002-04-01 | 2002-04-01 | Chinese medicine for treating hyperosteogeny and its prepn. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1375320A true CN1375320A (en) | 2002-10-23 |
Family
ID=4740647
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 02109377 Pending CN1375320A (en) | 2002-04-01 | 2002-04-01 | Chinese medicine for treating hyperosteogeny and its prepn. |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1375320A (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1319577C (en) * | 2003-12-17 | 2007-06-06 | 长春达兴药业股份有限公司 | Medicine for treating cervical disease and its preparation |
| CN102000201A (en) * | 2010-11-29 | 2011-04-06 | 杨凌无为制药集团有限公司 | Method for preparing anti-hyperosteogeny tablets |
| CN104107260A (en) * | 2013-04-20 | 2014-10-22 | 沈阳市骨科医院 | Pill for stopping bone hyperplasia |
| CN105327202A (en) * | 2015-11-04 | 2016-02-17 | 王国娟 | Traditional Chinese medicine preparation for treating bone hyperplasia |
| CN106798781A (en) * | 2017-02-20 | 2017-06-06 | 成都富豪斯生物科技有限公司 | It is a kind of to treat hypertrophic spondylitis, the Chinese medicine composition of cervical spondylopathy and preparation method |
-
2002
- 2002-04-01 CN CN 02109377 patent/CN1375320A/en active Pending
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1319577C (en) * | 2003-12-17 | 2007-06-06 | 长春达兴药业股份有限公司 | Medicine for treating cervical disease and its preparation |
| CN102000201A (en) * | 2010-11-29 | 2011-04-06 | 杨凌无为制药集团有限公司 | Method for preparing anti-hyperosteogeny tablets |
| CN104107260A (en) * | 2013-04-20 | 2014-10-22 | 沈阳市骨科医院 | Pill for stopping bone hyperplasia |
| CN105327202A (en) * | 2015-11-04 | 2016-02-17 | 王国娟 | Traditional Chinese medicine preparation for treating bone hyperplasia |
| CN106798781A (en) * | 2017-02-20 | 2017-06-06 | 成都富豪斯生物科技有限公司 | It is a kind of to treat hypertrophic spondylitis, the Chinese medicine composition of cervical spondylopathy and preparation method |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1861187A (en) | Medicated wine for treating rheumatosis and osteoarthropathy | |
| CN103735947B (en) | One treats osteoporotic Chinese medicine formula and preparation method thereof | |
| CN100394955C (en) | Chinese traditional medicine preparation for treating bone fracture and traumatic injury | |
| CN101537093A (en) | Chinese traditional medicine for preventing and curing osteoporosis and preparation method thereof | |
| CN1319569C (en) | Chinese medicine preparation for treating osteoporosis and fracture and preparation process thereof | |
| CN1129130A (en) | Medicament for treatment of cervical spondylopathy | |
| CN1375320A (en) | Chinese medicine for treating hyperosteogeny and its prepn. | |
| CN1406594A (en) | Oral Chinese medicine for osteoarthritis | |
| CN100333738C (en) | Chinese medicinal ointment for treating bone diseases | |
| CN101618129A (en) | Chinese medical preparation for treating rheumatoid osteopathia | |
| CN1324650A (en) | Effective medicine for treating cervical vertebra disease as one kind of intractable disease | |
| CN1824103A (en) | External use medicine for treating knocks and falls and bone joining | |
| CN106362066A (en) | Medicinal liquor for treatment of rheumatic and rheumatoid diseases and preparation method thereof | |
| CN1270055A (en) | Medical capsule for treating bone rheumatism and preparing process | |
| CN1054052C (en) | Comedo-elimination preparation | |
| CN1229118C (en) | Bone setting medicine | |
| CN1186056C (en) | medicine for treating hyperosteogeny | |
| CN1106848C (en) | Development of yaokang capsule and its clinical application | |
| CN1191751A (en) | Chinese medicine Gutongning and its preparation | |
| CN1284579C (en) | Oral medicine for treating ischemic necrosis of femoral head and its preparation | |
| CN102743531B (en) | Drug for treating cervical or lumbar diseases and preparation method thereof | |
| CN102247486A (en) | Bone health care marrow filling capsule | |
| CN1209140C (en) | Chinese medicine for treating bony spur, cervical vertebra and lumber intervertebral disc protrasion | |
| CN1891281A (en) | Chinese medicine preparation for treating wind-cold disease, and its preparing method | |
| CN1052162C (en) | Production method of traditional Chinese medicine pills for hyperostosis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |